university hopes are that a cocktail of the 2 might create

the reason is, oxford university, but they have donein is, oxford university, but they have done in making the vaccine is taking a chimpanzee cold virus, for chimpanzee virus, they used to chimpanzee virus, they used to chimpanzee virus, they used to chimpanzee virus, because people had not been exposed to vets they will have no prior immune response to it. they disabled that virus and added to it part of the code from the coronavirus. so that virus knows how to programme a sale to make the outer coat of coronavirus. in the idea is that you can check that into a person, it goes in and delivers those genetic instructions and makes the cells that pick it up to immune system would coronavirus looks like and this requires two doses of that vaccine in one criticism of this is that the immune system defends itself, not just against the coronavirus, but also builds a response against the chimpanzee virus when it goes in, so when you going with the next those there's, if they can combine but they did with astrazeneca with what they did with astrazeneca with what they did with moscow, and produce v

the coronavirus vaccine developed by astrazeneca and oxford university becomes the second vaccine in the uk to receive regulatory approval. the study‘s director says it is a landmark moment. it's a moment to celebrate and to have some optimism about where we've got to today, and moving forward. but we have to keep up this battle against the virus. the government has ordered 100 million doses, enough to vaccinate 50 million people. the health secretary says the first jabs will be given in the new year. today's news is great news for the ability of the vaccine to make us safe. and make us safe faster than we previously could have done. the news comes as more parts of england are to expected be moved into the highest level of coronavirus restrictions, tier 4. eu leaders sign the post—brexit trade deal agreed with britain on the eve of its departure from the eu single market, it will now be flown to london. here, the prime minister is due to start a debate in the house of commons shortly — as he asks mps to back the brexit trade deal in a vote this afternoon we'll have special cove

britain becomes the 1st country in the world to authorize emergency use of the astra zeneca oxford university back saying as the battle to base the coronavirus stepped up a gear bust awesome scene now becomes the 1st major country in latin america to legalize abortion it's a landmark decision for pro-choice activists and comes despite strong opposition from the catholic church. i'm rebecca rich's welcome to the program it's been months indeed years in the making and many doubted whether it would ever be agreed but today the post breaks a trade deal reached between the european union and the united kingdom is being formally ratified these top officials put their signatures on the 12100 page agreement in brussels the swarming the document has now been flown to london for prime minister forrest johnson to sign he has called the agreement afghans hassidic new relationship it's set to come into effect on new year's day when the brics transition period officially entrance you rick. well i'm joined now by our correspondents teri schultz in brussels and begin in london welcome to you both terry i'll

just as the uk become the first country to approve a vaccine from oxford university and aft rah zen ka, much of england moved into the high quest restriction. 3/4 of the population are under covid rules. prime minister boris johnson explained why. >> we've seen a 40% increase in cases in england in the last week alone. almost 15% more patients in hospital. more than at the peak of the first wave. so at this critical moment, with the prospect of freedom within reach, we've got to redouble our efforts to contain the virus. >> senior international correspondent matthew chance joins me now for more in london. and matthew, these numbers that we see, they're spiking, in many cases they are doubling, and yet so many people, millions of people in fact, will be waking up this new year's eve under further restrictions. >> reporter: yeah. i mean, look, britain is facing an incredibly dangerous situation when it comes to these holiday, these new year festivities. the british authorities have warned people not to go to parties. covid loves crowds, they've said. they've urged people to stay at home.

have approved a vaccine developed by oxford university at astra zeneca more than $50000.00.

approval vaccine developed by oxford university and astrazeca. more than 50,000 infections were reported there for a second day and millions more are moving into a tougher tear of restrictions. local media reports body-let strikes on the capital of yemen, after 24 people were killed in a blast at the airport in aden after members of yemen's newly-formed government returned from saudi arabia. a request for a new u.n. cease fire monitoring team to be set up in a city in libya. we have more from the united nations. correspondent: the security council asked the secretary-general back in february to come up with some ways to help libya, the international community very concerned, to help them move forward with a peace plan and a way to implement a cease-fire. that was before they even had a cease-fire in place. in october, the warring sides agreed to a tentative cease-fire and the secretary-general was asked to advance these recommendations. he has asked for more time to present them, citing ongoing peace talks between the parties. he has also been lo

oxford university and astrazeneca say it was a happy mistake. a small amount of people had been given a smaller dose, half a dose initially. when they followed that group through what they found is they had greater effectiveness. it was 90% as opposed to the bulk of the trial group which received two full doses, their figure was 62%. that's how you get that average, that 70% figure. what the u.k. is going with is two full doses because that's what the bulk of the data supports at this stage even though the researchers believe they have stumbled upon a sweet spot for increasing the effectiveness. the data is not yet there in enough size and volume to support that. they have to go out and essentially try and replicate those results on a bigger scale but that's going to take time. in the immediate future for this emergency use we're going with two full doses. the stated efficacy there is 62%. that is enough. that is enough they believe to make a big difference in battling this virus. >> this news is coming off the back of two record-breaking days,

britain becomes the 1st country in the world to authorize emergency use of the astra zeneca oxford university in fact same as the battle to think the coronavirus steps up again because. i am something becomes the 1st major country in latin america to legalize abortion but while pro-choice activists celebrate the landmark decision will it put the traditionally catholic country on a collision course with the church. oh . i'm rebecca races welcome to the program germany is reckoning with its highest daily coronavirus death toll to date for the 1st time since the pandemic began more than 1000 people have died in a single 24 hour period germany had a relatively low death rate of the 1st phase of the pandemic but has seen a steady increase in recent weeks restrictions meant to stem the spread of the virus have been tightened since november a current lockdown due to remain in place until january 10th now looks likely to be extended his german health minister against. making a little while ago wasn't going to run 61129 deaths this morning alone 1129 families will experience this new year in mourning

university it's the 2nd vaccine to receive emergency authorization from the u.k. authorities after the biotech pfizer jab trial data suggests the latest vaccine is less effective but easier to store and transport authorities say they plan to start rolling it out within days britain is struggling with a surge in virus cases that are threatening to overwhelm hospitals i'm not joined by john campbell he's an independent health analyst and educator and joins us from collin the north of england dr campbell thanks for joining us this pandemic is hitting your country and so many others very hard at this time how important is this new vaccine it really is but this new vaccine is the best news we've had in the pandemic it is going to change the situation entirely now in the united kingdom we're going to start a mass rollout of this vaccine from the 4th of january we're going to be vaccinating a 1000000 people a week from that point and that's certainly going to build up as the logistics and infrastructure develops and as well as that what we're going to do is we're going t

of officials in the united kingdom are expected to approve oxford university astra zeneca coronavirus eckstein in the coming days its low price and ease of storage will allow the government to back so many people more quickly according to a recent financial times report earlier this month you.

university and sputnik v. developed by russian. research institute you have a vaccine developers hope that combining their drugs could lead to a better immune response to the corona virus the clinical trials will be held in russian involve all in tears aged 18 over the job created by oxford university and astra zeneca it's shown results depending on the dose with an average efficacy of 70 percent compared with sputnik these results so far of over 90 percent. they have a problem that vaccines efficacy isn't high enough this should be improved we have 2 different ads a new viruses they will take one of them and use it as a booster molecular professor lawrence young told me that cross border cooperation is a vital component in talking the health crisis. i think it's a fine caustic opportunity to work together in developing a more effective vaccine and there's lots of evidence that when you mix and match different vaccine platforms you get stronger and longer lasting in your responses to our competition so this is

university hopes are that a cocktail of the 2 might create a stronger and or longer lasting vaccine for many up to now the idea of russians and brits working together to fight covert 19 may have seemed implausible in august the b.b.c. wrote russia's registration of sputnik has raised concerns about short cutting the normal process and just days ago the b.b.c. reported that sputnik v. has been rushed out to where we russians while backing the fast tracking of domestic vaccines the western media has worked hard to discredit the russian jab venture the competition is firstly being politicized and secondly dirty methods are being used to discredit our vaccine however sputnik is the 1st vaccine to have been produced it's secure good and in demand both the oxford and sputnik vaccines used harmless adenoviruses to fight covert 19 meanwhile russia's vaccine is growing in popularity as a solo contender about 50 countries have expressed interest in purchasing sputnik v argentina has already made a major investment. we will be able to count on enough doses to vaccinate $10000000.00 argentines

britain becomes the 1st country in the world to fall through as emergency use of the astra zeneca oxford university vaccine as the battle to beat the pandemic steps up a gear also in the program getting vaccinated mean you get more privileges germany's immunization campaign sparks new concerns over the country turning into a 2 tier society and. argentina becomes the 1st major country in latin america to legalize abortion the pro-choice activists celebrate a landmark decision. could think traditionally catholic country on a collision course with the church. hello i'm terry martin good to have you with us britain has become the 1st country in the world to authorize the corona virus vaccine developed by astra zeneca and offered university it's the 2nd vaccine to receive emergency authorization from u.k. authorities after the pfizer job trial data suggests the. scene is less effective but easier to store and transport authorities say they plan to start rolling it out within days britain is struggling with a surge in virus cases that are threatening to overwhelm hospitals for. for more let's

one of the scientists who led the development of the oxford university covid vaccine has warned that mixing over christmas could mean a sharp rise in infections injanuary. it comes amid warnings of the existing pressure on some hospitals, with one health board in wales suspending outpatient appointments and non urgent surgery. here's our science correspondent, pallab ghosh. although some are being vaccinated now, the majority of high—risk people will get theirjabs next year. the aim is to immunise those most at risk by easter. this would allow a gradual easing of restrictions across the country. professor sarah gilbert led efforts to develop the oxford university vaccine, currently being assessed for approval by the uk regulator. she warned people's behaviour in the coming weeks could delay progress in tackling the virus. what we have seen in the us is that after thanksgiving, when people were travelling and mixing, there's now been a big surge in infections and they're seeing 3000 deaths a day there now. the highest rate there has ever been in any country. if we have that kind of

vaccine has, this been developed by oxford university. oxford university has a standard on managing his electoral property. it has talked about open licenses. however, when they did the deal or the contract wit astrazeneca, he became exclusive cee for astrazeneca. they managed to put some conditio in the contract about making the vaccine accessible to veloping countries. so arazeneca went to one of the big vaccine producers in india, the serum institute, and ma an agreement to produce one billion doses. that is vaccinating 500 million people -- half of thewille in india. starta good way -- a good to make moreaccines available. astrazeneca also had some agreements with other countries like argentina and brazil so int means a number of peoe latin america. but what about the rest ofhe population? no production and such. astrazeneca compared to others, thingsey have done good an fixing a price -- astrazeneca says $4. for developing countries, probably three dollars per dose. so six dollars per person per course. -- young is, this is can't lea

could approve astra zeneca and oxford university's code in 1000 vaccines in just days which could fight the u.k. mutation as the country struggled to contain the spread of the virus. in the crown of our still eat a government funding bill after days of saying he opposed it we have a panel standing by him a lot to get to so let's get started. of officials in the united kingdom are expected to approve oxford university astra zeneca coronavirus eckstein in the coming days its low price and ease of storage will allow the government to vaccinate people more quickly according to a recent financial times report earlier this month u.k. officials approved the biotech pfizer vaccine which is harder to preserve and transport statistics now show at least $600000.00 people in the u.k. have received the pfizer vaccine so far the u.k. government efforts to ramp up vaccines comes as the country struggles with the new coronavirus strain that is more transmissible astra zeneca chief executive pasco soria also told the sunday times so far we think the vaccine should remain effective but we can't be sure s

have approved a vaccine develop a oxford university in astra zeneca the pharmaceutical giant has pledged to make $1300000000.00 doses available at cost to low and middle income countries or a challenge reports from london. if ever good news was needed in the u.k. it's now the numbers of new infections and hospitalizations are breaking records the deaths are almost as numerous as the peak in april and medics are sounding alarms that the health service is struggling to cope with cope with 2nd wave q a much anticipated announcement from the u.k.'s medicines regulator this vaccine kovac 19 facts astra zeneca has been approved for use in people and aged 18 years and older least 2 standard doses $4.00 to $12.00 weeks apart rollout begins on january the 4th with the oxford astra zeneca vaccine joining that of pfizer biotech and use in the u.k. since early december both are effective but the new vaccine has numerous advantages . here in this london vaccination center you can see some of the infrastructure that is needed to administer the pfizer biotech vaccine you can hear the generators running

vaccine with the astra zeneca virus fighter developed at oxford university hopes are that a cocktail of the 2 might create a stronger and or longer lasting vaccine. for many up to now the idea of russians and brits working together to fight covert 19 may have seemed implausible in august the b.b.c. wrote russia's registration of sputnik has raised concerns about short cutting the normal process and just days ago the b.b.c. reported that sputnik v. has been rushed out to where we russians while backing the fast tracking of domestic vaccines the western media has worked hard to discredit the russian jab thanks to the competition is firstly being politicized and secondly dirty methods are being used to discredit our vaccine however sputnik is the 1st vaccine to have been produced it's secure good and in demand both the oxford and sputnik vaccines used harmless adenoviruses to fight covert 19 meanwhile russia's vaccine is growing in popularity as a solo contender about 50 countries have expressed interest in purchasing sputnik v argentina has already made a major investment can almost ha